Interleukin-17 and neutrophils are increased in BAL fluid during acute lung rejection [6]

Chest

Volumn 131, Issue 6, 2007, Pages 1988-1989

  Verleden, Geert M ^a   Vos, Robin ^a   Vanaudenaerde, Bart M ^a   Van Raemdonck, Dirk ^a   Dupont, Lieven J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; INTERLEUKIN 17;

ACUTE GRAFT REJECTION; CELL DIFFERENTIATION; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE SEVERITY; HUMAN; LETTER; LUNG GRAFT REJECTION; LUNG LAVAGE; LYMPHOCYTE; NEUTROPHIL COUNT; NEUTROPHILIA; PRIORITY JOURNAL;

EID: 34250854639     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0473     Document Type: Letter

References (5)

1. Bhorade SM, Yu A, Vigneswaran WT, et al. Elevation of interleukin-15 protein expression in bronchoalveolar fluid in acute lung allograft rejection. Chest 2007; 131:533-538
2. Slebos D, Postma DS, Koeter GH, et al. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection. J Heart Lung Transplant 2004; 23:532-540
3. De Hoyos A, Chamberlain D, Schvartzman R, et al. Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest 1993; 103:1813-1818
4. Vanaudenaerde BM, Dupont LJ, Wuyts WA, et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27:779-787
5. Vanaudenaerde BA, Wuyts WA, Dupont LJ, et al. Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003; 22:1280-1283